Disclosure Panels Details Page
Head and Neck Cancers Panel - Disclosures as of 08/14/2015
|
Panel Member
(Spouse/Domestic Partner/Dependent) |
Clinical Research Support/Data Safety Monitoring Board | Scientific Advisory Boards, Consultant, or Expert Witness | Promotional Advisory Boards, Consultant, or Speakers Bureau | Employment/ Governing Board, Patent, Equity, or Royalty | Has Attended |
|---|---|---|---|---|---|
| David Adelstein MD | International Head and Neck Cancer Group - Singapore | None | None | None | ✔ |
| Marian Birkeland PhD | None | None | None | None | ✔ |
| David Brizel MD | None | medical legal case unrelated to any nccn activities | None | None | ✔ |
| Barbara Burtness MD | Boehringer Ingelheim GmbH Genentech, Inc. MedImmune Inc. Merck & Co., Inc. Novartis Pharmaceuticals Corporation VentiRx |
Amgen Inc. Johnson & Johnson |
Boehringer Ingelheim GmbH Merck & Co., Inc. Novartis Pharmaceuticals Corporation VentiRx |
None | ✔ |
| Paul Busse MD, PhD | None | None | None | None | - |
| Jimmy Caudell MD, PhD | None | None | None | None | ✔ |
| Anthony Cmelak MD | None | None | None | None | ✔ |
| A. Dimitrios Colevas MD | actogenix Bayer HealthCare Boehringer Ingelheim GmbH Bristol Myers Squibb california cancer consortium ecog Exelixis Inc. Genentech, Inc. GSK NCI rtog |
None | Bayer HealthCare | None | ✔ |
| Frank Dunphy MD | Bristol Myers Squibb | None | None | None | ✔ |
| David Eisele MD, FACS | None | None | None | None | ✔ |
| Robert Foote MD, FACR, FASTRO | None | None | None | None | ✔ |
| Lauren Gallagher | None | None | None | None | ✔ |
| Jill Gilbert MD | Eastern Cooperative Oncology Group National Cancer Institute |
None | None | None | - |
| Maura Gillison MD, PhD | Bristol Myers Squibb | Bristol Myers Squibb | Bristol Myers Squibb | None | ✔ |
| Kristina Gregory MSN, RN | None | None | None | None | ✔ |
| Robert Haddad MD | Boehringer Ingelheim GmbH Bristol Myers Squibb Celgene Corporation Merck & Co., Inc. Venti-Rx |
Bristol Myers Squibb Celgene Corporation Eisai Inc. Merck & Co., Inc. |
None | None | - |
| Bruce Haughey MBChB, MS | None | None | None | None | ✔ |
| Wesley Hicks, Jr. MD | None | None | None | None | ✔ |
| Ying Hitchcock MD | None | None | None | None | ✔ |
| Miranda Hughes PhD | None | None | None | None | ✔ |
| Antonio Jimeno MD, PhD | Boehringer Ingelheim GmbH Genentech, Inc. Novartis Pharmaceuticals Corporation Oncothyreon VentiRX Pharmaceuticals |
None | None | None | - |
| Merrill Kies MD | None | Merck & Co., Inc. | None | None | ✔ |
| William Lydiatt MD | None | None | None | None | - |
| Ellie Maghami MD, FACS | None | None | None | None | ✔ |
| Thomas McCaffrey MD, PhD | None | None | None | None | - |
| Joan McClure MS | None | None | None | None | ✔ |
| Nicole McMillian MS | None | None | None | None | ✔ |
| Loren Mell MD | Bristol Myers Squibb Genelux Inc. Varian Medical Systems, Inc. |
None | None | None | ✔ |
| Bharat Mittal MD | None | None | None | None | ✔ |
| David Pfister MD | AstraZeneca Pharmaceuticals LP Bayer HealthCare Boehringer Ingelheim GmbH Eli Lilly and Company Exelixis Inc. Genentech, Inc. GSK MedImmune Inc. Merck & Co., Inc. Novartis Pharmaceuticals Corporation |
Merck & Co., Inc. | None | None | ✔ |
| Harlan Pinto MD | Bristol Myers Squibb | None | Eli Lilly and Company | None | ✔ |
| Donna Powell DHSc, CMD, RT(T) | None | None | None | None | ✔ |
| John Ridge MD, PhD, FACS | None | None | None | None | - |
| Cristina Rodriguez MD | None | None | None | None | - |
| Jatin Shah MD, PhD | None | None | None | None | ✔ |
| Jack Skinner PhD | NA | NA | NA | NA | ✔ |
| Sharon Spencer MD | None | None | None | None | ✔ |
| Sarika Trikha PharmD | None | None | None | None | ✔ |
| Randal Weber MD | None | None | None | None | ✔ |
| Gregory Wolf MD | None | IRX Therapeutics | IRX Therapeutics | None | - |
| Francis Worden MD | Bayer HealthCare Bristol Myers Squibb Pfizer Inc. |
None | Bayer HealthCare | None | ✔ |
| Sue Yom MD, PhD, MAS | NA | NA | NA | NA | ✔ |